The Research Progress in Immunotherapy of Tuberculosis
Tuberculosis (TB) is a serious public health problem worldwide. The combination of various anti-TB drugs is mainly used to treat TB in clinical practice. Despite the availability of effective antibiotics, effective treatment regimens still require long-term use of multiple drugs, leading to toxicity...
Guardado en:
Autores principales: | Jie Mi, Yan Liang, Jianqin Liang, Wenping Gong, Shuyong Wang, Junxian Zhang, Zhiming Li, Xueqiong Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8879e2e53777414da90bd916f9bcabc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection
por: Sherry L. Kurtz, et al.
Publicado: (2020) -
Sputum Smear Non-conversion at the End of Intensive Phase of Tuberculosis Treatment at a Tertiary Center: A Descriptive Cross-sectional study
por: Naveen Prakash Shah, et al.
Publicado: (2021) -
Tuberculosis múltiple
por: DANERI N,JULIO
Publicado: (1944) -
Colo‐appendico‐duodenal fistula: Rare presentation of extrapulmonary tuberculosis
por: David Eng Yeow Gan, et al.
Publicado: (2021) -
Tuberculosis en patrón esporotricoide: una presentación inusual de tuberculosis cutánea en un paciente inmunocompetente
por: Downey,Camila, et al.
Publicado: (2015)